gamma-aminobutyric acid has been researched along with Hearing Loss in 5 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The main aim of this study was to assess the effect of gabapentin on tinnitus via a systematic review." | 8.87 | Gabapentin for tinnitus: a systematic review. ( Aazh, H; El Refaie, A; Humphriss, R, 2011) |
| "We report a patient with acute renal failure who developed hearing loss, myoclonus, and confusion with hallucinations in the presence of elevated gabapentin concentrations." | 7.74 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "Gabapentin is an antiepileptic agent indicated for use as an adjunct therapy in partial seizures and postherpetic neuralgia but is also prescribed for the treatment of diabetic peripheral neuropathy." | 5.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "We report a patient with acute renal failure who developed hearing loss, myoclonus, and confusion with hallucinations in the presence of elevated gabapentin concentrations." | 5.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "The patient's symptoms (hearing loss, myoclonus, and confusion) improved after 1 session of hemodialysis (approximately 10 hours following admission) and had resolved at the time of discharge (4 days later)." | 5.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "The main aim of this study was to assess the effect of gabapentin on tinnitus via a systematic review." | 4.87 | Gabapentin for tinnitus: a systematic review. ( Aazh, H; El Refaie, A; Humphriss, R, 2011) |
| "We report a patient with acute renal failure who developed hearing loss, myoclonus, and confusion with hallucinations in the presence of elevated gabapentin concentrations." | 3.74 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "One consequence of hearing loss is changes in evoked release at surviving auditory nerve synapses, and in some situations spontaneous release is greatly enhanced." | 2.47 | Short-term plasticity and auditory processing in the ventral cochlear nucleus of normal and hearing-impaired animals. ( Manis, P; O'Donohue, H; Wang, Y, 2011) |
| "Gabapentin is an antiepileptic agent indicated for use as an adjunct therapy in partial seizures and postherpetic neuralgia but is also prescribed for the treatment of diabetic peripheral neuropathy." | 1.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "We report a patient with acute renal failure who developed hearing loss, myoclonus, and confusion with hallucinations in the presence of elevated gabapentin concentrations." | 1.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "The patient's symptoms (hearing loss, myoclonus, and confusion) improved after 1 session of hemodialysis (approximately 10 hours following admission) and had resolved at the time of discharge (4 days later)." | 1.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brecht, EJ | 1 |
| Barsz, K | 1 |
| Gross, B | 1 |
| Walton, JP | 1 |
| Reijntjes, DOJ | 1 |
| Pyott, SJ | 1 |
| Pierce, DA | 1 |
| Holt, SR | 1 |
| Reeves-Daniel, A | 1 |
| Wang, Y | 1 |
| O'Donohue, H | 1 |
| Manis, P | 1 |
| Aazh, H | 1 |
| El Refaie, A | 1 |
| Humphriss, R | 1 |
3 reviews available for gamma-aminobutyric acid and Hearing Loss
| Article | Year |
|---|---|
The afferent signaling complex: Regulation of type I spiral ganglion neuron responses in the auditory periphery.
Topics: Acetylcholine; Action Potentials; Animals; Animals, Newborn; Cochlea; Dendrites; Dopamine; gamma-Ami | 2016 |
Short-term plasticity and auditory processing in the ventral cochlear nucleus of normal and hearing-impaired animals.
Topics: Animals; Auditory Pathways; Calcium; Calcium Channels; Cochlea; Cochlear Nucleus; gamma-Aminobutyric | 2011 |
Gabapentin for tinnitus: a systematic review.
Topics: Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Hearing L | 2011 |
2 other studies available for gamma-aminobutyric acid and Hearing Loss
| Article | Year |
|---|---|
Increasing GABA reverses age-related alterations in excitatory receptive fields and intensity coding of auditory midbrain neurons in aged mice.
Topics: 4-Aminobutyrate Transaminase; Acoustic Stimulation; Aging; Animals; Anticonvulsants; Auditory Percep | 2017 |
A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure.
Topics: Acute Kidney Injury; Amines; Anticonvulsants; Anuria; Comorbidity; Cyclohexanecarboxylic Acids; Diab | 2008 |